Our study uncovers a novel oncogenic axis in DLBCL, where SMIT1’s carcinogenic potential is epigenetically modulated by WTAP/YTHDF1-mediated m6A methylation. The gene discussed is WTAP; the disease is diffuse large B-cell lymphoma.